Benzinga | Aug 10, 2021 09:05AM EDT

UBS Initiates Coverage On Blend Labs with Neutral Rating, Announces Price Target of $20

UBS analyst Karl Keirstead initiates coverage on Blend Labs (NYSE:BLND) with a Neutral rating and announces Price Target of $20.